SI1725552T1 - Novi kvaternizirani kinuklidin estri - Google Patents

Novi kvaternizirani kinuklidin estri

Info

Publication number
SI1725552T1
SI1725552T1 SI200530293T SI200530293T SI1725552T1 SI 1725552 T1 SI1725552 T1 SI 1725552T1 SI 200530293 T SI200530293 T SI 200530293T SI 200530293 T SI200530293 T SI 200530293T SI 1725552 T1 SI1725552 T1 SI 1725552T1
Authority
SI
Slovenia
Prior art keywords
quinuclidine esters
new
new quaternized
esters
quaternized quinuclidine
Prior art date
Application number
SI200530293T
Other languages
English (en)
Slovenian (sl)
Inventor
Forner Maria Dolors Fernandez
Quinones Maria Prat
Albero Maria Antonia Buil
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of SI1725552T1 publication Critical patent/SI1725552T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200530293T 2004-03-15 2005-03-10 Novi kvaternizirani kinuklidin estri SI1725552T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200400638A ES2239546B1 (es) 2004-03-15 2004-03-15 Nuevos esteres de quinuclidina cuaternizados.
EP05729711A EP1725552B1 (en) 2004-03-15 2005-03-10 New quaternized quinuclidine esters
PCT/EP2005/002523 WO2005090342A1 (en) 2004-03-15 2005-03-10 New quaternized quinuclidine esters

Publications (1)

Publication Number Publication Date
SI1725552T1 true SI1725552T1 (sl) 2008-10-31

Family

ID=34955916

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530293T SI1725552T1 (sl) 2004-03-15 2005-03-10 Novi kvaternizirani kinuklidin estri

Country Status (30)

Country Link
US (1) US20080214600A1 (enExample)
EP (1) EP1725552B1 (enExample)
JP (1) JP2007529444A (enExample)
KR (1) KR20070003940A (enExample)
CN (1) CN1930158A (enExample)
AR (1) AR048004A1 (enExample)
AT (1) ATE399166T1 (enExample)
AU (1) AU2005223310A1 (enExample)
BR (1) BRPI0508177A (enExample)
CA (1) CA2560157A1 (enExample)
CY (1) CY1108324T1 (enExample)
DE (1) DE602005007714D1 (enExample)
DK (1) DK1725552T3 (enExample)
EC (1) ECSP066770A (enExample)
ES (2) ES2239546B1 (enExample)
HR (1) HRP20080338T3 (enExample)
IL (1) IL177341A0 (enExample)
MY (1) MY142036A (enExample)
NO (1) NO20064659L (enExample)
NZ (1) NZ548583A (enExample)
PE (1) PE20060005A1 (enExample)
PL (1) PL1725552T3 (enExample)
PT (1) PT1725552E (enExample)
RS (1) RS50566B (enExample)
RU (1) RU2382041C2 (enExample)
SI (1) SI1725552T1 (enExample)
TW (1) TW200604196A (enExample)
UA (1) UA88634C2 (enExample)
WO (1) WO2005090342A1 (enExample)
ZA (1) ZA200605931B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
MX2009008323A (es) * 2007-02-15 2009-08-13 Argenta Discovery Ltd Derivados heterociclicos como receptores muscarinicos m3.
BRPI0816219B8 (pt) 2007-09-07 2021-05-25 Theravance Biopharma R&D Ip Llc compostos contendo guanidina úteis como antagonistas de receptor muscarínico, composição farmacêutica e uso
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
EP2222637A1 (en) 2007-12-14 2010-09-01 Theravance, Inc. Amidine-containing compounds useful as muscarinic receptor antagonists
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
JP5902612B2 (ja) 2009-04-09 2016-04-13 ノバルティス アーゲー ピロリジニウム塩の調製方法
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
HK1212986A1 (zh) * 2012-12-05 2016-06-24 奇斯药制品公司 作为pde4-抑制剂的苯基乙基吡啶衍生物
CN103755698A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一锅法制备阿地溴铵的工艺
CN103755699A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一种2-羟基-2,2-二噻吩-2-基乙酸-1-氮杂二环[2,2,2]辛-3(r)-基酯制备方法
KR101511090B1 (ko) 2014-04-24 2015-04-10 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
KR100869721B1 (ko) * 2000-12-28 2008-11-21 알미랄 에이쥐 신규한 퀴누클리딘 유도체 및 그를 함유한 의약 조성물
EP1438309A1 (en) * 2001-10-17 2004-07-21 Ucb, S.A. Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
PE20060005A1 (es) 2006-01-28
DK1725552T3 (da) 2008-10-13
RU2006136085A (ru) 2008-04-27
EP1725552B1 (en) 2008-06-25
ECSP066770A (es) 2006-11-16
TW200604196A (en) 2006-02-01
IL177341A0 (en) 2006-12-10
CA2560157A1 (en) 2005-09-29
ATE399166T1 (de) 2008-07-15
PL1725552T3 (pl) 2008-12-31
RU2382041C2 (ru) 2010-02-20
ES2239546B1 (es) 2006-12-01
CN1930158A (zh) 2007-03-14
KR20070003940A (ko) 2007-01-05
ES2239546A1 (es) 2005-09-16
MY142036A (en) 2010-08-16
JP2007529444A (ja) 2007-10-25
HRP20080338T3 (hr) 2008-07-31
CY1108324T1 (el) 2014-02-12
ES2307168T3 (es) 2008-11-16
AR048004A1 (es) 2006-03-15
US20080214600A1 (en) 2008-09-04
WO2005090342A1 (en) 2005-09-29
PT1725552E (pt) 2008-09-18
HK1101855A1 (en) 2007-10-26
AU2005223310A1 (en) 2005-09-29
UA88634C2 (en) 2009-11-10
RS50566B (sr) 2010-05-07
NO20064659L (no) 2006-12-13
DE602005007714D1 (de) 2008-08-07
NZ548583A (en) 2010-05-28
ZA200605931B (en) 2007-11-28
EP1725552A1 (en) 2006-11-29
BRPI0508177A (pt) 2007-08-07

Similar Documents

Publication Publication Date Title
ZA200709985B (en) Transesterification methods
ZA200700252B (en) Azaindole carboxamides
IL181330A0 (en) Thiazolo-naphthyl acids
IL177341A0 (en) New quaternized quinuclidine esters
DE502005003298D1 (en) Ls
GB0422000D0 (en) Model options
SG119251A1 (en) Methods
ZA200701433B (en) Selection
IL182559A0 (en) Improved liquifier
GB0403629D0 (en) Methods
GB0418756D0 (en) Supports
GB0423552D0 (en) Methods
EP1782298A4 (en) CONSTRUCTION PROCESS
GB0414104D0 (en) Support
GB0415757D0 (en) Methods
PL1786977T3 (pl) Przejazd kolejowy
PL115193U1 (en) Anchor-attached support
AU3838P (en) Zanlorsanna Lilium hybrid
GB0424179D0 (en) Rotating cattlegrid
GB0401085D0 (en) Methods
GB0413206D0 (en) Methods
GB0401514D0 (en) Methods
GB0403966D0 (en) Methods
GB0406479D0 (en) Methods
GB0426632D0 (en) Methods